Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paul Rothman Insider Profile
4 Followers
Paul Rothman, Director at Merck & Company, holds 100.00 shares in Merck & Company (Ticker: MRK), holds 5.00K shares in Cancer Genetics (Ticker: CGIX).
Paul Rothman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Paul Rothman holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Paul Rothman
Paul Rothman's Trading History
Merck & Company
Sep 02, 2015
Director
Uninformative Buy
―
$7.99K
Cancer Genetics
May 27, 2014
Director
Uninformative Buy
―
$12.20K
List of latest transactions for each holding click on a transaction to see Paul Rothman's performance on stock
You May Also Like
Paul Rothman insider profile FAQ
What is the percentage of profitable transactions made by Paul Rothman?
The percentage of profitable transactions made by Paul Rothman is ―.
What is the average return per transaction made by Paul Rothman?
The average return per transaction made by Paul Rothman is ―.
What stocks does Paul Rothman hold?
Paul Rothman holds: MRK, CGIX stocks.
What was Paul Rothman’s latest transaction?
Paul Rothman latest transaction was an Uninformative Buy of ―.
What was Paul Rothman's most profitable transaction?
Paul Rothman’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Paul Rothman's role in Merck & Company?
Paul Rothman's role in Merck & Company is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.